<div id="readability-page-1"><img width="2560" height="1707" src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2026/01/anil-baki-durmus-wD5luapwXmM-uns-scaled.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2026/01/anil-baki-durmus-wD5luapwXmM-uns-scaled.jpg"/>Palladyne AI (NASDAQ: PDYN) soared nearly 50% this morning after announcing a new contract with the US Air Force Research Laboratory (AFRL).The contract is for a project titled “Hierarchical Adaptive Networked Game-Theoretic Integration of Multiple Echelons” or simply “HANGTIME”.According to PDYN’s press release, this initiative aims at solving a critical bottleneck in modern warfare – getting different autonomous systems to work as a single, coordinate team.Still, for a disciplined investor, the massive subsequent surge in Palladyne stock may just be a “sell the news” opportunity for the following three irrefutable reasons.<h2>Palladyne stock is a ‘sell’ due to massive fundamental disconnect</h2>Despite the AFRL contract win, PDYN stock’s financial reality remains rather “jarring”. It doesn’t change the fact that this Nasdaq-listed firm is burning cash at an alarming rate, with a net margin of negative 953%.Palladyne’s operating loss stands at over $40 million currently on just $4.3 million in trailing sales. While executives have hiked the 2026 outlook to about $25 million, the stock is already trading at 56x sales.Simply put, markets are pricing in “perfect execution” of a 400% growth spurt that hasn’t happened yet – leaving almost no room for the inevitable integration hiccups that come with their three recent acquisitions.<h2>Looming dilution cliff makes PDYN shares unattractive in 2026</h2>PDYN remains unappealing also because it recently filed a $54 million shelf registration, which acts like a “dam” holding back new shares.With Palladyne shares soaring 30% today, the incentive for the Nasdaq-listed firm to tap into this shelf to raise capital is at an all-time high.For a company with a market cap of $350 million, a $54 million share offering will mean massive dilution for current shareholders.Rallies on “government contract” news are the classic window for small-cap firms to execute these secondary offerings, often erasing the day’s gains overnight.In fact, following initial excitement, PDYN has already started selling off in recent hours. At the time of writing, it’s hovering around $8.0 only versus an intraday high of more than $9.50.This suggests the explosive move on January 28th was more speculative than fundamentals backed.<h2>Why else is Palladyne AI worth selling into the strength?</h2>Finally, defense contracts, especially those involving “Research Laboratories” like the AFRL, are often phased and “milestone-based” rather than lump-sum payments.While the HANGTIME project sounds revolutionary, these early-stage integration contracts often have low margins and high R&amp;D requirements.Here’s what this means: unless the contract converts to high-margin recurring software revenue, PDYN remains structurally fragile.That’s partly why Wall Street analysts currently rate Palladyne AI Corp at “hold” only, with price targets going as low as $7, signaling potential downside of more than 12% over the next 12 months.The post Palladyne stock: 3 big reasons to sell it on Air Force contract rally appeared first on Invezz</div>

PDYNW

PDYN

Palladyne AI (NASDAQ: PDYN) surged nearly 50% after securing a contract with the US Air Force for the HANGTIME project. However, analysts suggest selling the stock due to significant financial concerns, including a negative net margin of 953% and an operating loss exceeding $40 million. Additionally, a $54 million shelf registration raises dilution risks for shareholders. The contract's phased payment structure may also limit profitability, leading to a cautious outlook from Wall Street, with price targets indicating potential declines.